Medical device for nitric oxide therapy application in clinical settings. Equipped with features for precise gas delivery and patient monitoring. Approved for use in cardiovascular and critical care applications.
Manufactured by
NANJING NOVLEAD BIOTECHNOLOGY CO., LTD.
Nanjing, China
Novlead Biotech was established in Nanjing, China in April 2018. Based on the self-developed Nitric Oxide Instant Generation Molecular Technology (NOGMT) platform, the company focuses on the R D and production of innovative medical device products, and is committed to solving major clinical problems in the cardiopulmonary, respiratory and anti-infection fields, providing breakthrough clinical solutions in terms of gas detection and treatment. The founders of Novlead have solid international experience onscientific research and professional environment , specializing in the R D and commercialization of technologies related to medical gas detection and treatment. The core management team consists of experts with rich clinical and medical management experience, professors in NO controlled-release and generation technology, senior experts in biological sciences and high-end life-supporting medical equipment, many of whom have studied abroad and have executive experience in Fortune 500 companies.
© 2026 Suplivia · Home · Browse Products